Adopt AI Grand Palais 2025
Manifesto
Replays
Program
Partners
Exhibitors
Speakers
Become a sponsor 2026
1
All Stages
REPLAYS
1
Dates
Nov 25
Nov 26
Morning/Afternoon
Loading
ECOSYSTEMS
1
Clear all filters
All Stages
CEO Stage
Mainstage North
Masterclass North
Startup Stage
AI for Health Grand Palais Opening Ceremony
Including special video address from Dr. Tedros Adhanom Ghebreyesus
SM
Sébastien
Marguerès
Artefact
Director AI for Health & Public Affairs
DTAG
Dr. Tedros
Adhanom Ghebreyesus
World Health Organization
Director General
Agents: The AI-Powered Path to Improve Patients' Outcomes
Led by Prof. Stéphanie Allassonnière, this panel unites leaders from AWS, Bristol Myers Squibb, Bioptimus, and the NHS to explore how AI agents are redefining patient care. The conversation...
PSA
Prof. Stéphanie
Allassonnière
University Paris Cité
Vice President Valorisation & Chair of the Prairie Institute
MS
Mathilda
Ström
Bioptimus
Founding Chief Operating Officer
PIA
Prof. Ian
Abbs
Guy's and St Thomas' NHS Foundation Trust
Strategic Advisor, Former CEO
EC
Emma
Charles
Bristol Myers Squibb
Senior Vice President European Markets
AM
Arafat
Mlika
Amazon Web Services
Global Sales Leader & Life Sciences Business Development Lead
Redefine the Future of Health: Leading with AI
WM
Walid
Mehanna
Merck Group
Chief Data & AI Officer
EO
Emre
Ozcan
Merck Group
Global Head of Digital Health & Devices
Bridging AI Innovation From Bench to Bed
DGP
Dr. Grégoire
Pigné
PulseLife
CEO & Co-Founder, Oncologist Radiotherapist
DOV
Dr. Olivier
Véran
InnOV
Former French Minister of Social Affairs and Health & Former Government Spokesperson & CEO & Founder of InnOV
PS
Peter
Schardt
Siemens Healthineers
Chief Technology Officer
DNJ
Dr. Nasheed
Jamal
BIOSerenity
Chief Marketing Officer
RG
Reda
Guiha
Pfizer
Country President France
FIRESIDE CHAT: THE FUTURE OF AI IN HEALTH WITH PAUL HUDSON, CEO SANOFI
A discussion on AI’s role in personalized healthcare and pharmaceutical innovation
PH
Paul
Hudson
Sanofi
CEO
CR
Charlotte
Reed
CNBC
Journalist
Transforming Hospitals Through On-Premise Generative AI
AD
Anwar
Dahab
Dell Technologies
Senior Vice President & Managing Director France
PR
Paul
Rinaudo
ADLIN Science
CEO & Founder
PDM
Prof. David
Morquin
Montpellier UHC
Head of AI Strategy & Data Governance
AF
Anne
Ferrer-Villeneuve
Montpellier UHC
Managing Director
AI SERVING PATIENTS: FROM TARGET TO TREATMENT
A global healthcare company governed by a non-profit foundation, Servier leverages AI for one clear purpose: to innovate faster, with and for patients—especially in rare diseases.
VD
Virginie
Dominguez
Servier
Executive VP, Information Systems, Digital, Data & AI
OL
Olivier
Laureau
Servier
President and CEO
From Innovation to Clinical Impact: New Approaches for AI in Rare Diseases
AD
Arthur
Delapalme
Codoc
CEO & Co-Founder
DVP
Dr. Virginie
Pichon
Angers UHC
Neurologist & Rare Disease Network Expert
PPC
Prof. Philippe
Codron
Angers UHC
Professor & Neurologist
SC
Susanna
Cirulli
HIMSS
Programme Manager EMEA
TG
Thibaud
Guymard
Biogen
Head of Innovation, Services & Digital
Smart Hospitals: Infrastructure & Tools for Tomorrow’s Healthcare
PPG
Prof. Pierre-Antoine
Gourraud
Nantes UHC
Professor & Healthcare Practitioner
DSVQ
Dr. Solène
Vo Quang
Hack Your Care
Surgeon, CEO & Founder
PAT
Prof. Antoine
Tesnière
PariSanté Campus
Managing Director
DML
Dr. Michael
Lauk
B. Braun
Chief Digital Officer
Servier Hackathon Award Ceremony
BM
Brice
Miranda
Servier
Chief Data & AI Officer
AM
Ahmad
Murtada
Servier
Chief Digital Transformation Officer
OL
Olivier
Laureau
Servier
President & CEO
VD
Virginie
Dominguez
Servier
Executive Vice President, Information Systems, Digital, Data & AI
Driving Efficiency: AI Solutions for the Field Force Evolution
AI-Driven Strategies boost pharmaceutical sales by enhancing sales force efficiency and overall productivity. Utilising advanced training, real-life simulations, and behavioral analysis of both...
SO
Shana
Owen
Vivanti
Strategic Partnerships & Key Client Manager
How AI Is Reshaping Care in Rare Diseases & Endocrinology?
Moderated by D. Braun, this session will explore digital health initiatives led by Merck Digital Health team. The focus will be on pediatric endocrinology, examining how a connected auto-injection...
DCT
Dr. Cécile
Teinturier
Bicêtre Hospital AP-HP
Pediatric Endocrinologist
IM
Imogen
Marouillat
Merck
Head of Solution Delivery for Global Digital Health
DB
David
Braun
Merck
Head of Commercial Operations & Customer Engagement for Global Digital Health
FM
Fulvio
Michelis
Merck
Digital Health Product Owner for Global Digital Health
Federated health data space: How to boost collaboration on health data… without exposing sensitive...
Introducing Tune Insight's Federated Health Data Space
BS
Bertrand
Spilthooren
Tune Insight
Digital-health strategist and team manager
Why chatbots are the worst way to use Genai ?
Uncover why relying on chatbots wastes Genai’s potential & learn how end-to-end, collaborative workflows drive real ROI and measurable impact across your organization.
ADT
Antoine
De Torcy
Biolevate
Chief AI & Product Officer
How human–AI agents in all-in-one platforms accelerate time-to-market for medical device companies
Bringing a medical device to market is complex — documentation, validation, and compliance take time. This session shows how human–AI agents collaboration inside all-in-one platforms can accelerate...
CR
Charles
Rollet
TraceX
CEO
Leveraging Data, Digital & AI to Better Serve Customers in Need
Observations on key aspects in defining strategies around Data, Digital and AI to serve customer in needs.
MG
Marco
Giannitrapani
Novartis
Vice President Global Data & Analytics
Multi-modal data structuration : why data is the next bottleneck of AI development ?
From clinical data to omics data, integration of multi-modal data will be next challenge of IA development in the healthcare sector. ADLIN focuses in accompanying public and private actors to...
PR
Paul
Rinaudo
ADLIN Science
CEO & Founder
AH
Adel
Houhou
ADLIN Science
Business Development Manager
Understanding the CE Marking Challenges of LLM-based Medical Devices
Large Language Models (LLMs) are increasingly used to power clinical decision support and healthcare professional recommendation systems. Turning these technologies into compliant medical devices...
EN
Elisa
Negra
Sparta Care
Co-CEO & Co-founder
Enabling the European Health Data Space (EHDS)
The European Health Data Space (EHDS) regulation is set to transform healthcare innovation by breaking down silos and enabling the secure secondary use of health data for research, AI development,...
RD
Régis
Dioulo
Nvidia
Healthcare Lead France
YM
Yves
Mahieu
Pure Storage
International Industry Principal, Healthcare & Life Sciences
Building Trust in AI: The Role of Data Ownership and Sovereignty
In this session, we explore how secure and sovereign data forms the foundation for responsible and trustworthy AI systems. As artificial intelligence becomes increasingly embedded in business,...
JAR
Jai’ Amir
Ramjankhan
Apura Cloud
Co Founder
Use of AI gamification to discover behavioral patterns of children
Did you know that we could turn gameplay into insight? Through hypercasual mobile games, we can quietly capture how kids focus, decide, and react. Behind every tap, swipe, and pause — there’s a...
DP
Dmitry
Pavlotsky
Game Analyze
Co-Founder & CMO
Digital Longevity Medicine
In 2024, Professor Dean Ho and his team launched DELTA – a groundbreaking human trial with Professor Ho himself as the test subject. DELTA combines AI, digital health, fasting, fitness, and...
PDH
Prof. Dean
Ho
WisDM - National University of Singapore
Head of the Department of Biomedical Engineering & Provost's Chair Professor & Director
Prevent the Preventable: AI for Early Detection
This session introduces ANRISK, an AI-driven risk prediction platform developed by TALOS Corp., built on the mission to “Prevent the Preventable.” By leveraging large-scale national health checkup...
TK
Tackeun
KIM
Talos
CEO & Neurosurgeon
Responsibly deploying AI in mental health
As the name suggests, general-purpose AI models are used in all sorts of ways, including addressing mental health challenges. While they can provide helpful support, they lack a psychological...
HK
Hannes
Klöpper
HelloBetter
CEO & Founder
AI Shaping a New Era of Chronic Disease Management
Upon completion of this masterclass attendees will: 1. Understand how AI can recognize chronic diseases from an ECG and Coronary Artery disease opportunistically from CT scans 2. Learn how to...
DMS
Dr. Melvin
Speisman
American College of AI and Medicine
President
DAS
Dr. Andrea
Slasuraitis
American College of AI and Medicine
Vice President
Call for Abstracts Scientific Session
TT
Tiziana
Tocci
Institut Curie
PhD Candidate
HH
Hasti
Honari
Institut Curie
PhD Candidate
BR
Balthazar
Raffy
MSInsight
Bioinformatician
BG
Bora
Guloglu
InstaDeep
Senior Research Scientist
DAG
Dr. Arman
Gorji
Neuroscience & Neoplasia AI Research Group (NAIRG)
Co-Founder & Head
UG
Ulysse
Gimenez
BIOSerenity
Data Science Director
Scaling Agentic AI in a World Leading Pharma Company
AK
Aditya
Kudumala
Deloitte
Partner & Global AI Lead for Life Sciences
KS
Kaoutar
Sghiouer
Sanofi
Group Chief Data & AI Officer
AI for Health Grand Palais Day 2 - Opening Words
Opening Day 2
SM
Sébastien
Marguerès
Artefact
Director AI for Health & Public Affairs
The Midas Touch: Transforming Real-World Oncology Data Through Collective Intelligence
PV
Pascaline
Villié
AP-HP
Project Director, Innovation & Data Division
AM
Amaury
Martin
Institut Curie
Chief Innovation & Growth Officer
SO
Sophie
Ollivier
Servier
Chief Data Officer R&D
BG
Benjamin
Garel
Paris Saclay Cancer Cluster
CEO
Human. Machine. Care
JB
Jan
Beger
GE HealthCare
Global Head of AI Advocacy
1
2
